Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nature. Author manuscript; available in PMC 2009 May 4.
Published in final edited form as:
PMCID: PMC2666538

MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs


Herpesviruses are characterized by their ability to maintain life-long latent infections in their animal hosts. However, the mechanisms that allow establishment and maintenance of the latent state remain poorly understood. Herpes simplex virus 1 (HSV-1) establishes latency in neurons of sensory ganglia, where the only abundant viral gene product is a non-coding RNA, the latency associated transcript (LAT)1,2. Here, we show that LAT functions as a primary microRNA (miRNA) precursor that encodes four distinct miRNAs in HSV-1 infected cells. One of these miRNAs, miR-H2-3p, is transcribed antisense to ICP0, a viral immediate-early transcriptional activator thought to play a key role in productive HSV-1 replication and reactivation from latency3. miR-H2-3p is indeed able to reduce ICP0 protein expression, but does not significantly affect ICP0 mRNA levels. We also identified a fifth HSV-1 miRNA in latently infected trigeminal ganglia, miR-H6, which derives from a previously unknown transcript distinct from LAT. miR-H6 displays extended seed complementarity to the mRNA encoding a second HSV-1 transcription factor, ICP4, and inhibits expression of ICP4, which is required for expression of most HSV-1 genes during productive infection4. These results may explain the reported ability of LAT to promote latency5-9. Thus, HSV-1 expresses at least two primary miRNA precursors in latently infected neurons that may facilitate the establishment and maintenance of viral latency by post-transcriptionally regulating viral gene expression.

HSV-1 LAT is an ~8.3 kb capped, polyadenylated RNA (Fig. 1a)1,2 that is spliced to give an ~2.0 kb stable intron and a predicted unstable ~6.3 kb exonic RNA10,11. As LAT is not thought to encode a protein, we hypothesized that the exonic regions of LAT might function as a primary miRNA precursor12. To identify HSV-1 LAT-derived miRNAs, we constructed a LAT expression plasmid, pcDNA3/LAT, in which a heterologous promoter drives transcription of an ~10.8 kb HSV-1 genomic fragment containing the entire 8.3 kb LAT (Fig. 1a). We transfected this plasmid into human 293T cells and isolated total RNA. Northern analysis revealed high-level expression of the stable LAT intron (Fig. 1b).

Genomic location of HSV-1 miRNAs. a. Schematic of the HSV-1 genome expanded to display details of the LAT locus. Relative sizes, locations and orientations of other viral transcripts in this region are indicated. Sequence coordinates of viral miRNAs and ...

Small RNAs derived from this sample were used to prepare cDNAs for 454 sequencing13. This resulted in 225,439 sequence reads (Suppl. Table 1), of which at least 144,955 represented cellular miRNAs (Suppl. Table 2A). We also recovered 651 HSV-1-derived miRNAs (Suppl. Tables 1 and 3). Six HSV-1 miRNA sequences were obtained, derived from four HSV-1 miRNA precursor hairpins (Fig. 2a). The two most common HSV-1 miRNAs were miR-H2-3p (265 reads) and miR-H4-3p (266 reads) and these derived from miRNA stem-loops that also gave rise to star strands miR-H2-5p (10 reads) and miR-H4-5p (61 reads) (Fig. 2a). We also detected miR-H3 (5 reads) and miR-H5 (40 reads). For each miRNA, HSV-1 LAT could be folded into the expected precursor stem-loop structure. Where both the miRNA and star strand were recovered, the characteristic ~2 nt 3′ overhangs were observed in the duplex intermediate (Fig. 2a).

Fig. 2
2HSV-1 pre-miRNAs. a. Predicted secondary structures of HSV-1 miRNA precursors, demonstrating the characteristic stem-loops. Mature miRNAs are indicated in red and, where observed, star strands in blue. Number of reads of each recovered mature miRNA sequence ...

These data show that LAT can be processed into miRNAs in culture but do not address expression in vivo. We therefore isolated small RNAs from trigeminal ganglia (TG) of mice latently infected with HSV-1 and performed deep sequencing of derived cDNAs. We obtained 254,651 sequence reads (Suppl. Table 1), of which at least 204,867 represent cellular miRNAs (Suppl. Table 2B). An additional 164 sequences represented HSV-1 miRNAs (Suppl. Tables 1 and 4). miR-H2-3p (94 reads), miR-H3 (18 reads) and miR-H5 (1 read) represent LAT-derived miRNAs previously identified in LAT-expressing 293T cells (Fig. 2a). However, a fourth HSV-1 miRNA, miR-H6 (50 reads), derives from an RNA stem-loop transcribed from the opposite strand of the HSV-1 genome, within the LAT promoter (Fig. 1a). This sequence was not present in pcDNA3/LAT and therefore could not be detected in transfected 293T cells. Of the total of 171 HSV-1 short RNAs detected in TG, 27 were obtained only once. Of these, 20 represent truncations or point mutants of miR-H2 through miR-H6, while 7 appear to represent random HSV-1 RNA breakdown products (Suppl. Table 1 and data not shown).

The identification of miR-H6 is striking for two reasons. Firstly, miR-H6 must derive from a second HSV-1 primary miRNA precursor, distinct from LAT, expressed in latently infected neurons. While a transcript antisense to the LAT promoter has been described14, the reported ends of this transcript exclude miR-H6. The lack of previous reports describing this primary miRNA precursor may reflect the fact that it must be cleaved to generate miR-H6, and hence is likely unstable. Secondly, the stem-loop that gives rise to miR-H6 lies antisense to a stem-loop transcribed from the opposite DNA strand that gives rise to a previously described HSV-1 miRNA, miR-H1 (Fig. 2a). miR-H1 is expressed late in productive replication,15 and miR-H6 and miR-H1 show extensive sequence complementarity (Fig. 2b). The unusual phenomenon of distinct miRNAs derived by bidirectional transcription of a single genomic locus was recently also described in mouse cytomegalovirus16.

To ascertain whether any of these HSV-1 miRNAs are expressed during productive HSV-1 infection, where LAT is expressed late in infection11, we performed quantitative stem-loop RT-PCR for miR-H2-3p through miR-H6 using RNA from HSV-1 infected Vero cells. The cellular miRNA let-7a was used as an internal control for RNA recovery. All five novel HSV-1 miRNAs were, in fact, detected in infected Vero cells using RT-PCR (Fig. 2c and Suppl. Table 5A) and/or Northern analysis (Suppl. Fig. 2d). The “non-LAT” HSV-1 miRNA miR-H6 was detected at 105.0 molecules per ng of isolated short (i.e., <200 nt) RNA, while the four LAT-derived miRNAs were detected at between 102.7 (miR-H3) and 104.1 (miR-H2-3p) molecules per ng (Fig. 2c and Suppl. Table 5A). These data confirm that all five novel HSV-1 miRNAs are indeed expressed in productively infected cells.

RT-PCR analysis of pcDNA3/LAT-transfected 293T cells (Fig. 2c) also detected all four LAT-derived miRNAs, but as expected did not detect miR-H6, which is not present in this vector. Analysis of short RNAs derived from mouse TG demonstrated the expression of all four LAT-derived HSV-1 miRNAs, as well as miR-H6 (Fig. 2c and Suppl. Table 5A). There is a relatively poor correlation between the levels of expression of each HSV-1 miRNA, as extrapolated from deep sequencing, when compared to the qRT-PCR analysis. This presumably reflects differences in the efficiency of cDNA synthesis.

The qRT-PCR analysis presented in Fig. 2c and Suppl. Table 5A allows us to roughly estimate how many copies of each HSV-1 miRNA are present in productively infected Vero cells versus latently infected neurons. During productive infection, miR-H1 and miR-H6 are expressed at ~1200 and ~300 copies per Vero cell. In contrast, the LAT-derived HSV-1 miRNAs miR-H2-3p through miR-H5 are all present at <40 copies per cell (Suppl. Table 6A). These latter levels may be too low to exert a significant phenotypic effect. In latently infected TG, our estimate is based on a previous report that mice latently infected with the HSV-1 strain KOS contain ~500 LAT-expressing neurons per TG17. Based on this report, we estimate ~6.3 × 104 copies per LAT+ neuron for miR-H2-3p, ~4 × 104 copies/LAT+ neuron for miR-H6 and ~8 × 105 copies/LAT+ neuron for miR-H4-3p. We also detected substantial levels of miR-H4-5p (~3.2 × 104 copies/LAT+ neuron), thus suggesting that the star strand of miR-H4 might also be a functional miRNA (Fig. 2c and Suppl. Table 6C). Even if our estimate of the number of latently HSV-1 infected neurons per TG is low by an order of magnitude18, the level of HSV-1 miRNAs per neuron would still be within the range of cellular miRNAs that is biologically active12.

Although we were able to detect several different HSV-1 miRNAs in both LAT-expressing 293T cells and infected Vero cells, using a range of techniques, we did not detect the previously described miR-LAT19 (Suppl. Figs. 1 and 2). The report describing miR-LAT was recently retracted.

Mapping of the six HSV-1 miRNAs onto the HSV-1 genome reveals that miR-H2 is antisense to the ICP0 transcript, while both miR-H3 and miR-H4 are antisense to ICP34.5 (Fig. 1a). ICP0 is an HSV-1 transcriptional activator, expressed as an immediate-early gene, that promotes viral replication and may facilitate reactivation from latency3,20,21. To examine whether miR-H2-3p could affect ICP0 protein or mRNA expression, we transfected 293T cells with either a wildtype ICP0 expression plasmid or a derivative containing three point mutations within the predicted miR-H2-3p seed region (Fig. 3a). These plasmids were co-transfected with plasmids designed to express an shRNA that mimics the predicted miR-H2 pre-miRNA (Fig. 2a and Suppl. Fig. 3) or a mutated version of the miR-H2 pre-miRNA (miR-H2/3M) that bears three mutations in the miR-H2-3p seed region that restore complementarity to the ICP0 mutant (Fig.3a). As shown in Fig. 3b, the wildtype miR-H2 pre-miRNA inhibited expression of wildtype, but not mutant, ICP0 protein. Conversely, expression of the mutant ICP0 protein was reduced upon co-expression of the mutant miR-H2/3M pre-miRNA but was not affected by wildtype miR-H2. While these data demonstrate that miR-H2-3p is indeed acting through the expected target site to inhibit ICP0 protein expression, this inhibition did not correlate with a reduction in the level of ICP0 mRNA (Fig. 3c). Similar data, obtained using siRNA duplexes designed to mimic the miR-H2 or miR-H2/3M miRNA duplex intermediate, and using RNAse protection to measure ICP0 mRNA expression, are presented in Suppl. Fig. 3. Together, these data show that, despite the perfect complementarity of miR-H2-3p to ICP0 mRNA, inhibition of ICP0 protein expression by this viral miRNA occurs primarily at the translational level12. These data are consistent with earlier reports suggesting that LAT reduces ICP0 protein, but not mRNA, levels in infected cells.22,23

Fig. 3
Downregulation of ICP0 protein expression by HSV-1 miR-H2-3p. a. Sequence of miR-H2-3p bound to ICP0 mRNA. The miRNA seed region is indicated in gray. Arrows indicate complementary nucleotide changes introduced into the mutant ICP0 expression plasmid ...

Analysis of other HSV-1 genes revealed sequence similarity between miR-H6, including an extended miRNA seed region,12 and the mRNA encoding ICP4, a transcription factor required for expression of most HSV-1 genes during productive infection (Fig. 4a)4. Co-transfection of an ICP4 expression plasmid with a synthetic form of the predicted miR-H6 duplex intermediate revealed strong downregulation of ICP4 protein expression (Fig. 4b), while an ICP4 expression construct with three mutations in the seed region of the predicted miR-H6 target site remained unaffected. Analysis of wildtype ICP4 mRNA expression levels showed that miR-H6 co-expression had little or no inhibitory effect (Fig. 4C).

Fig. 4
Downregulation of ICP4 protein expression by HSV-1 miR-H6. a. Sequence complementarity of miR-H6 to nucleotides 127,298 to 127,319 of the ICP4 mRNA. Grey box indicates the miRNA seed region. Arrows indicate nucleotide changes present in the ICP4 mutant. ...

In this manuscript, we report the identification of five novel HSV-1 miRNAs, three of which were previously computationally predicted15,24. Four of these viral miRNAs derive from the second exon of the spliced ~6.3 kb LAT (Fig. 1a) and these miRNAs may provide both a rationale for the existence of spliced LAT and explain its characteristic instability1,11, i.e., LAT is likely degraded in the nucleus due to Drosha cleavage12. In addition to the four LAT-derived HSV-1 miRNAs, we also identified a fifth miRNA, miR-H6, derived from a currently unknown primary miRNA precursor that lies antisense to the LAT promoter and that must also be expressed in latently infected neurons (Fig. 1a). Of interest, miR-H6 lies antisense to a known late HSV-1 miRNA, miR-H115.

Three of the latently expressed HSV-1 miRNAs are transcribed antisense to HSV-1 mRNAs—ICP0 mRNA in the case of miR-H2-3p and ICP34.5 mRNA in the case of both miR-H3 and miR-H4-3p (Fig. 1a)—and we have demonstrated that miR-H2-3p is indeed able to inhibit ICP0 protein expression (Fig. 3b). As ICP0 is a key immediate-early HSV-1 transcriptional activator that may promote entry into the productive replication cycle3,20,21, inhibition of ICP0 expression by miR-H2-3p may increase the likelihood that neurons enter and maintain latency. It has in fact been previously proposed that LAT inhibits ICP0 expression post-transcriptionally in neurons2,10,23 and the existence of miR-H2-3p could explain this phenomenon. We also observed that miR-H6 displays partial complementarity to ICP4 mRNA, including an extended miRNA seed region12, and can reduce ICP4 protein expression (Fig. 4). Like ICP0, ICP4 can promote exit from latency21, and inhibition of ICP4 expression may therefore enhance the robustness of the latent state.

While we have not directly examined the effect of miR-H3 and miR-H4-3p on ICP34.5 expression, it appears likely that these viral miRNAs are also acting as inhibitors of viral gene expression. Data favouring this hypothesis come from analysis of the L/ST transcripts that overlap the 3′ end of LAT (Fig. 1a). L/ST RNAs are expressed by HSV-1 mutants lacking ICP425. Importantly, the L/ST RNAs, which have the potential to give rise to miR-H3 and miR-H4-3p (Fig. 1a), are known to inhibit ICP34.5 expression via an “antisense” mechanism26,27 and these viral miRNAs are presumably responsible for this effect. In conclusion, our observation that HSV-1 miRNAs are capable of downregulating key viral immediate early proteins is consistent with the recent proposal, based primarily on computational data, that herpesviruses in general may use viral miRNAs “as part of their strategy to enter and maintain latency.”28

Methods Summary

pcDNA3/LAT expresses an ~10.8 kb EcoRV to BamHI fragment, derived from the KOS strain of HSV-1, which extends 134 bp 5′, and ~2.3 kb 3′, to LAT. Small RNAs were prepared using standard techniques from 293T cells transfected with pcDNA3/LAT or from the dissected TG of mice latently infected with HSV-1 strain KOS 30 days previously. cDNAs were prepared and subjected to 454 sequencing13. Vero or SY5Y cells were infected with HSV-1 strain KOS or strain 17syn+ at 10 pfu/cell and RNA harvested for RT-PCR analysis 14 to 18 hrs post-infection. Northern and Western blot analyses were performed using standard methods. Stem-loop RT-PCR methods are described in supplementary materials.

Supplementary Material

Suppl Data

Suppl Methods


We thank Rozanne Sandri-Goldin for reagents used in this research and Sandrine Boissel for contributions to PCR primer design. This work was supported by National Institutes of Health grants to B.R.C. and D.M.C.


1. Bloom DC. HSV LAT and neuronal survival. Int Rev Immunol. 2004;23:187–198. [PubMed]
2. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science. 1987;235:1056–1059. [PubMed]
3. Everett RD. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays. 2000;22:761–770. [PubMed]
4. Preston CM. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol. 1979;29:275–284. [PMC free article] [PubMed]
5. Chen SH, Kramer MF, Schaffer PA, Coen DM. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol. 1997;71:5878–5884. [PMC free article] [PubMed]
6. Garber DA, Schaffer PA, Knipe DM. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol. 1997;71:5885–5893. [PMC free article] [PubMed]
7. Thompson RL, Sawtell NM. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol. 2001;75:6660–6675. [PMC free article] [PubMed]
8. Thompson RL, Sawtell NM. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol. 1997;71:5432–5440. [PMC free article] [PubMed]
9. Sawtell NM, Thompson RL. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol. 1992;66:2157–2169. [PMC free article] [PubMed]
10. Farrell MJ, Dobson AT, Feldman LT. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A. 1991;88:790–794. [PubMed]
11. Kang W, et al. Characterization of a spliced exon product of herpes simplex type-1 latency-associated transcript in productively infected cells. Virology. 2006;356:106–114. [PubMed]
12. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. [PubMed]
13. Hafner M, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods. 2008;44:3–12. [PMC free article] [PubMed]
14. Perng GC, et al. A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5′ end of the latency-associated transcript produces a protein in infected rabbits. J Virol. 2002;76:8003–8010. [PMC free article] [PubMed]
15. Cui C, et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J Virol. 2006;80:5499–5508. [PMC free article] [PubMed]
16. Dölken L, et al. Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol. 2007;81:13771–13782. [PMC free article] [PubMed]
17. Feldman LT, et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A. 2002;99:978–983. [PubMed]
18. Sawtell NM. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol. 1997;71:5423–5431. [PMC free article] [PubMed]
19. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature. 2006;442:82–85. [PubMed]
20. Cai W, et al. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol. 1993;67:7501–7512. [PMC free article] [PubMed]
21. Halford WP, Kemp CD, Isler JA, Davido DJ, Schaffer PA. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol. 2001;75:6143–6153. [PMC free article] [PubMed]
22. Chen SH, et al. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J Virol. 2002;76:4764–4772. [PMC free article] [PubMed]
23. Thompson RL, Shieh MT, Sawtell NM. Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo. J Virol. 2003;77:12319–12330. [PMC free article] [PubMed]
24. Pfeffer S, et al. Identification of virus-encoded microRNAs. Science. 2004;304:734–736. [PubMed]
25. Yeh L, Schaffer PA. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J Virol. 1993;67:7373–7382. [PMC free article] [PubMed]
26. Randall G, Roizman B. Transcription of the derepressed open reading frame P of herpes simplex virus 1 precludes the expression of the antisense gamma(1)34.5 gene and may account for the attenuation of the mutant virus. J Virol. 1997;71:7750–7757. [PMC free article] [PubMed]
27. Lee LY, Schaffer PA. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts. J Virol. 1998;72:4250–4264. [PMC free article] [PubMed]
28. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A. 2008;105:5453–5458. [PubMed]